• Genoa in the News

Genoa Healthcare® featured in Chain Drug Review’s 2022 Industry Outlook

Jan 21st, 2022

Genoa Healthcare Chief Executive Officer Joe Douglas provides outlook for 2022

2022 will be another important year for the behavioral health community. The increase in mental illness and substance use disorder, along with the staffing challenges and shift to telehealth that we saw in 2021, will continue to impact the health care industry. Our pharmacy teams are prepared to step up with additional services that meet the changing needs of our partners and consumers.

Genoa Healthcare Chief Executive Officer Joe Douglas takes a look at the opportunities for expanded access to care in 2022 and provides an industry outlook in Chain Drug Review’s 2022 forecast. You can read the full article here or view it in Chain Drug Review’s recent issue.

Recent Posts

  • Pharmacy Openings
Celebrating Genoa Healthcare’s 700th pharmacy

Genoa Healthcare celebrated an exciting milestone – the grand opening of its 700th on-site pharmacy – at the Advocates mental health center in Framingham. The debut was marked with a ribbon...

  • Clinical Insights
Frequently asked questions: naloxone (Narcan®)

Narcan® information and sources were taken from www.narcan.com. 1. FDA Approves First Over-the-Counter Naloxone Nasal Spray. 3/29/2023. FDA Approves First Over-the-Counter Naloxone Nasal Spray | FDA

  • Blog Post
Genoa Pharmacist faces winter snowstorm to deliver consumers’ medications

When Watertown, New York, Pharmacist Meredith Sullivan made the call to close her pharmacy in preparation for an incoming snowstorm on Friday, Dec. 23, she wondered how the pharmacy’s closure...

  • Pharmacy Openings
Announcing three new pharmacy openings!

We’re excited to announce the opening of three pharmacies last month. We welcome all new pharmacy staff to the team and are excited to partner with these organizations to serve...